• Vacancy: Head of Operations-JB GROUPNovember 18, 2026
    JB Group invites applications from suitably qualified and experienced professionals for the position of Head of Operations. The successful candidate will provide strategic and operational leadership across the Group’s retail network, driving sales performance, profitability, operational efficiency, customer experience… Read more: Vacancy: Head of Operations-JB GROUP
  • Turning the Private Sector into a real engine of growthNovember 18, 2026
    STAFF WRITER editors@thepatriot.co.bw RelatedPosts Turning the Private Sector into a real engine of growth Leading Botswana’s Digital Future Stanbic enters the bourse With Botswana’s fiscal buffers depleted and public debt climbing toward the critical 40 percent Gross Domestic Product… Read more: Turning the Private Sector into a real engine of growth
  • Many ancestral land claims looming Boko warned against his CKGR planNovember 18, 2026
    SOLOMON TJINYEKA editors@thepatriot.co.bw RelatedPosts Many ancestral land claims looming Boko warned against his CKGR plan BDP deals under in the spotlight Parley probes buying of P25m Texas bulls More power for Moti As President Duma Boko throws away caution… Read more: Many ancestral land claims looming Boko warned against his CKGR plan
  • BDP deals under in the spotlight Parley probes buying of P25m Texas bullsNovember 17, 2026
    Masisi BDP’s government procurement comes under spotlight Parliament moves to investigate buying of USA cattle, Aussie dairy goats Assistant Minister of Agriculture Motsamai backs the probes   BAKANG TIRO RelatedPosts Many ancestral land claims looming Boko warned against his… Read more: BDP deals under in the spotlight Parley probes buying of P25m Texas bulls
  • More power for Moti As President Duma Boko throws away caution about being conflictedNovember 16, 2026
    After being granted Botswana citizenship, claims are that he could be appointed Ambassador at Large • Maele defends Moti’s citizenship, reveals his ambitious investment plans locally • Zunaid Moti’s latest investment interest expands to Chrome Mining in Botswana RelatedPosts… Read more: More power for Moti As President Duma Boko throws away caution about being conflicted
  • Home
  • News
  • Business
  • Lifestyle
  • Sport
  • Analysis & Opinions
  • Vacancies & Tenders
  • Login
  • Register
Sunday, November 22, 2026
The Patriot On Sunday
Advertisement
  • Home
  • News
  • Business
  • Lifestyle
  • Sport
  • Analysis & Opinions
  • Vacancies & Tenders
No Result
View All Result
Cart / $0.00

No products in the cart.

  • Home
  • News
  • Business
  • Lifestyle
  • Sport
  • Analysis & Opinions
  • Vacancies & Tenders
No Result
View All Result
The Patriot On Sunday
No Result
View All Result

China-developed COVID-19 vaccine produces immune response in phase II human trial

patriot by patriot
November 20, 2020
in News
0

Two COVID-19 vaccine candidates, one from China and the other from the UK, have proven safe for humans and produced strong immune reactions among patients involved in two separate clinical trials, the Lancet medical journal announced on 20th July. The trial of Ad5-nCOV, the vaccine developed by China, has yielded “much better” results in its Phase II in terms of the safety and ability to trigger immune response. The paper said Phase III trials are needed to confirm whether the vaccine candidate effectively protects against SARS-CoV-2 infection. The vaccine developer is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on 18th July.

The first trial, which the World Health Organization (WHO) claims is leading the global vaccine race, is from Oxford University. It’s regarded as one of the most advanced for development. 

RelatedPosts

Many ancestral land claims looming Boko warned against his CKGR plan

BDP deals under in the spotlight Parley probes buying of P25m Texas bulls

More power for Moti As President Duma Boko throws away caution about being conflicted

On Monday, the university published its results from the first phase of human trials, which involved more than 1,000 adults in UK aged between 18 and 55.

Scientists say the vaccine contains a “double protection” against the disease. Not only does it produce antibodies – which are the immune system’s natural response – it also produces T-cells that directly kill virus infected cells.

“Well I think there’s increasing evidence that having a T-cell response as well as antibodies could be very important in controlling COVID-19,” professor Adrian Hill, Director of the Jenner Institute, Oxford University told CGTN.

“We see people who’ve recovered from a COVID illness who have essentially no measurable antibodies but do have T-cells. So the guess there is that the T-cells have been important in helping them to clear their infection,” Hill said. 

The UK vaccine, called AZD1222, is developed by AstraZeneca and scientists at Oxford University. Authors say further clinical studies, including in older adults, should be done with this vaccine. 

Current results focus on immune response measured in the laboratory. Further testing is needed to confirm if the vaccine effectively protects against infection.

‘Chinese counterpart’

A separate trial in China involving 508 people has also yielded “much better” results in its Phase II in terms of the safety and ability to trigger immune response, a previous study shows.

The Chinese vaccine, named Ad5-nCOV, is developed by CanSino Biologics Inc and a military research unit. The Lancet said Phase 3 trials are needed to confirm whether the vaccine candidate effectively protects against SARS-CoV-2 infection.

According to the company, China’s success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials.

The vaccine developer is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on Saturday.

“We are contacting Russia, Brazil, Chile and Saudi Arabia (for the Phase III trial), and it’s still in discussion,” Qiu Dongxu, executive director and co-founder of CanSino, told an anti-viral drug development conference in Suzhou, in east China’s Jiangsu Province.

Global vaccine race

The two are among more than 21 candidate vaccines that have shown promise in human testing, along with projects involving Moderna, BioNTech, and Inovio Pharmaceuticals, according to Margaret Harris, spokeswomen at WHO. 

“We know we’ve got lots of options here, but we can’t put it down to days of weeks,” she told CGTN when asked if it’s possible to make more accurate projections on vaccine timetables. 

Harris also mentioned it’s important to look at not only how to accelerate relevant researches and keep on sharing, but also how to distribute this fairly, who to prioritize and ensure that those most at risk are protected first.

Tags: ChinaCOVID-19vaccine

Get real time update about this post categories directly on your device, subscribe now.

Unsubscribe
Previous Post

Mapetla drops 6th album

Next Post

Overcoming Economic and Social Challenges amid and after COVID-19

Related Posts

Many ancestral land claims looming  Boko warned against his CKGR plan
News

Many ancestral land claims looming Boko warned against his CKGR plan

November 18, 2026
BDP deals under in the spotlight Parley probes buying of P25m Texas bulls
News

BDP deals under in the spotlight Parley probes buying of P25m Texas bulls

November 17, 2026
More power for Moti As President Duma Boko throws away caution about being conflicted
News

More power for Moti As President Duma Boko throws away caution about being conflicted

November 16, 2026
LEA promotes fodder production
News

LEA promotes fodder production

November 11, 2026
Top DCEC spooks fed up
News

Top DCEC spooks fed up

November 10, 2026
Two UDC MPs allegedly beaten at a pub   UDC MPs demand DIS protection
News

Two UDC MPs allegedly beaten at a pub UDC MPs demand DIS protection

November 9, 2026
Next Post
Minister Kgafela worried about projects’ delays

Minister Kgafela worried about projects’ delays

Please login to join discussion
  • Vacancy: Head of Operations-JB GROUPNovember 18, 2026
    JB Group invites applications from suitably qualified and experienced professionals for the position of Head of Operations. The successful candidate will provide strategic and operational leadership across the Group’s retail network, driving sales performance, profitability, operational efficiency, customer experience… Read more: Vacancy: Head of Operations-JB GROUP
  • Turning the Private Sector into a real engine of growthNovember 18, 2026
    STAFF WRITER editors@thepatriot.co.bw RelatedPosts Turning the Private Sector into a real engine of growth Leading Botswana’s Digital Future Stanbic enters the bourse With Botswana’s fiscal buffers depleted and public debt climbing toward the critical 40 percent Gross Domestic Product… Read more: Turning the Private Sector into a real engine of growth
  • Many ancestral land claims looming Boko warned against his CKGR planNovember 18, 2026
    SOLOMON TJINYEKA editors@thepatriot.co.bw RelatedPosts Many ancestral land claims looming Boko warned against his CKGR plan BDP deals under in the spotlight Parley probes buying of P25m Texas bulls More power for Moti As President Duma Boko throws away caution… Read more: Many ancestral land claims looming Boko warned against his CKGR plan
  • BDP deals under in the spotlight Parley probes buying of P25m Texas bullsNovember 17, 2026
    Masisi BDP’s government procurement comes under spotlight Parliament moves to investigate buying of USA cattle, Aussie dairy goats Assistant Minister of Agriculture Motsamai backs the probes   BAKANG TIRO RelatedPosts Many ancestral land claims looming Boko warned against his… Read more: BDP deals under in the spotlight Parley probes buying of P25m Texas bulls
  • More power for Moti As President Duma Boko throws away caution about being conflictedNovember 16, 2026
    After being granted Botswana citizenship, claims are that he could be appointed Ambassador at Large • Maele defends Moti’s citizenship, reveals his ambitious investment plans locally • Zunaid Moti’s latest investment interest expands to Chrome Mining in Botswana RelatedPosts… Read more: More power for Moti As President Duma Boko throws away caution about being conflicted
The Patriot On Sunday

© 2024 Copyright The Patriot On Sunday - Inspired by Search Mart.

Navigate Site

  • About Us
  • Advertise
  • Disclaimer
  • Contact Us

Follow Us

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Login
  • Sign Up
  • Cart
  • Home
  • News
  • Business
  • Lifestyle
  • Sport
  • Analysis & Opinions
  • Vacancies & Tenders

© 2024 Copyright The Patriot On Sunday - Inspired by Search Mart.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Not enough quota to unlock this post

To unlock this post, you need 1 quotas

Unlock left : 0
Are you sure want to cancel subscription?